We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Ultomiris
Australian Public Assessment Report
Device/Product Name
Ultomiris
Active ingredients
Ravulizumab
AusPAR Date
Published
Submission Number
PM-2021-01659-1-6
Submission Type
Extension of indications
Decision
Approved